AtriCure (ATRC) News Today $30.02 +0.73 (+2.49%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$30.03 +0.01 (+0.03%) As of 05/2/2025 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Aquatic Capital Management LLC Sells 15,898 Shares of AtriCure, Inc. (NASDAQ:ATRC)Aquatic Capital Management LLC cut its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 40.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,102 shares of the medical device company's stock after selling 15,898 shares duMay 4 at 4:37 AM | marketbeat.comPDT Partners LLC Acquires 15,626 Shares of AtriCure, Inc. (NASDAQ:ATRC)PDT Partners LLC raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 65.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,327 shares of the medical device company's stock after buyMay 3 at 5:59 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Stake Trimmed by Barclays PLCBarclays PLC lessened its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 33.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company's stock after selling 4May 3 at 3:39 AM | marketbeat.comUBS Group Cuts AtriCure (NASDAQ:ATRC) Price Target to $58.00May 3 at 2:45 AM | americanbankingnews.comAtriCure's (ATRC) "Market Outperform" Rating Reiterated at JMP SecuritiesMay 3 at 2:45 AM | americanbankingnews.comAtriCure (ATRC) Shares Cross Below 200 DMAMay 2 at 11:23 PM | nasdaq.comUBS Group Issues Pessimistic Forecast for AtriCure (NASDAQ:ATRC) Stock PriceUBS Group dropped their price objective on AtriCure from $60.00 to $58.00 and set a "buy" rating on the stock in a research report on Wednesday.May 2 at 10:52 AM | marketbeat.comAtriCure (NASDAQ:ATRC) Given Market Outperform Rating at JMP SecuritiesJMP Securities reaffirmed a "market outperform" rating and issued a $60.00 price target on shares of AtriCure in a report on Wednesday.May 2 at 10:52 AM | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst DowngradeAtriCure (NASDAQ:ATRC) Shares Gap Down on Analyst DowngradeMay 2 at 10:28 AM | marketbeat.comAtriCure (NASDAQ:ATRC) Price Target Lowered to $44.00 at Needham & Company LLCNeedham & Company LLC reduced their price objective on shares of AtriCure from $51.00 to $44.00 and set a "buy" rating for the company in a research report on Wednesday.May 2 at 8:37 AM | marketbeat.comEmerald Mutual Fund Advisers Trust Sells 230,096 Shares of AtriCure, Inc. (NASDAQ:ATRC)Emerald Mutual Fund Advisers Trust reduced its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 92.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,408 shares of the medical devicMay 2 at 6:08 AM | marketbeat.comSusquehanna Fundamental Investments LLC Invests $3.18 Million in AtriCure, Inc. (NASDAQ:ATRC)Susquehanna Fundamental Investments LLC acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 104,094 shares of the medical device compMay 2 at 5:04 AM | marketbeat.comNebula Research & Development LLC Sells 9,703 Shares of AtriCure, Inc. (NASDAQ:ATRC)Nebula Research & Development LLC decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 35.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,363 shares of the medical device compMay 2 at 4:56 AM | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Price Up 4.9% Following Earnings BeatAtriCure (NASDAQ:ATRC) Trading 4.9% Higher After Earnings BeatMay 1 at 4:46 PM | marketbeat.comAtriCure (NASDAQ:ATRC) Issues Quarterly Earnings ResultsAtriCure (NASDAQ:ATRC - Get Free Report) announced its quarterly earnings data on Tuesday. The medical device company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.25) by $0.11. AtriCure had a negative net margin of 9.61% and a negative return on equity of 6.80%.May 1 at 4:21 PM | marketbeat.comShareholders in AtriCure (NASDAQ:ATRC) have lost 40%, as stock drops 11% this past weekMay 1 at 9:08 AM | finance.yahoo.comAdage Capital Partners GP L.L.C. Makes New $9.17 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Adage Capital Partners GP L.L.C. bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 300,000 shares of the medical device company's stock, valMay 1 at 5:12 AM | marketbeat.com4ATRC : 14 Analysts Assess AtriCure: What You Need To KnowApril 30, 2025 | benzinga.comAtriCure (ATRC) Buy Rating Reaffirmed Despite Adjusted Price Target | ATRC Stock NewsApril 30, 2025 | gurufocus.comAtriCure (ATRC) Target Price Revised Amid Mixed Sector Performance | ATRC Stock NewsApril 30, 2025 | gurufocus.comAtriCure, Inc. (NASDAQ:ATRC) is First Light Asset Management LLC's 4th Largest PositionFirst Light Asset Management LLC raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 5.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,969,221 shares of the medical device company's stock after acquiringApril 30, 2025 | marketbeat.comAtriCure Inc (ATRC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...April 30, 2025 | finance.yahoo.comAtriCure (NASDAQ:ATRC) Shares Up 4.9% on Better-Than-Expected EarningsApril 30, 2025 | americanbankingnews.comAtriCure Earnings PreviewApril 30, 2025 | benzinga.comAtriCure, Inc. (ATRC) Q1 2025 Earnings Call TranscriptApril 29, 2025 | seekingalpha.comAtriCure Reports First Quarter 2025 Financial ResultsApril 29, 2025 | businesswire.comRaymond James Financial Inc. Makes New $3.72 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Raymond James Financial Inc. purchased a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 121,591 shares of the medical device compaApril 29, 2025 | marketbeat.comWells Fargo & Company MN Sells 37,874 Shares of AtriCure, Inc. (NASDAQ:ATRC)Wells Fargo & Company MN lessened its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 39.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,407 shares of the medical device company's sApril 28, 2025 | marketbeat.comOberweis Asset Management Inc. Buys New Holdings in AtriCure, Inc. (NASDAQ:ATRC)Oberweis Asset Management Inc. acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 151,500 shares of the medical device cApril 27, 2025 | marketbeat.com25,164 Shares in AtriCure, Inc. (NASDAQ:ATRC) Bought by Dark Forest Capital Management LPDark Forest Capital Management LP purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 25,164 shares of the medical device company'sApril 27, 2025 | marketbeat.comCanada Pension Plan Investment Board Grows Stake in AtriCure, Inc. (NASDAQ:ATRC)Canada Pension Plan Investment Board raised its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 756.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,100 shares of the medicApril 27, 2025 | marketbeat.comHood River Capital Management LLC Raises Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Hood River Capital Management LLC raised its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,923,731 shares of the medical devApril 25, 2025 | marketbeat.comNatixis Makes New $1.85 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Natixis acquired a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 60,500 shares of the medical device company's stock, valued at approximately $1,849,000. Natixis owned approximately 0.12April 25, 2025 | marketbeat.comAtriCure (ATRC) Expected to Announce Earnings on TuesdayAtriCure (NASDAQ:ATRC) will be releasing its Q1 2025 earnings after the market closes on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-atricure-inc-stock/)April 24, 2025 | marketbeat.comJump Financial LLC Sells 54,296 Shares of AtriCure, Inc. (NASDAQ:ATRC)Jump Financial LLC decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 65.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,878 shares of the medical device company's sApril 24, 2025 | marketbeat.comMarshall Wace LLP Has $18.92 Million Stake in AtriCure, Inc. (NASDAQ:ATRC)Marshall Wace LLP grew its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 37.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 619,166 shares of the medical device company's stock after aApril 22, 2025 | marketbeat.comRenaissance Technologies LLC Boosts Holdings in AtriCure, Inc. (NASDAQ:ATRC)Renaissance Technologies LLC grew its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 67.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 163,900 shares of the medical device company's stoApril 22, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Recommendation of "Buy" by BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have received a consensus recommendation of "Buy" from the nine analysts that are covering the firm, Marketbeat.com reports. Nine analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers thApril 20, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest UpdateAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,340,000 shares, a decline of 21.2% from the March 15th total of 1,700,000 shares. Based on an average daily volume of 612,800 shares, the days-to-cover ratio is presently 2.2 days. Approximately 2.8% of the shares of the stock are sold short.April 20, 2025 | marketbeat.comChamplain Investment Partners LLC Has $77.27 Million Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Champlain Investment Partners LLC lessened its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 9.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,528,614 shares of the medical device company's stock aApril 19, 2025 | marketbeat.comWasatch Advisors LP Trims Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Wasatch Advisors LP decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 21.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 607,364 shares of the medical device company's stock afterApril 19, 2025 | marketbeat.comFranklin Resources Inc. Decreases Holdings in AtriCure, Inc. (NASDAQ:ATRC)Franklin Resources Inc. cut its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 33.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,966 shares of the medical device company's stock after selling 18,87April 17, 2025 | marketbeat.comRussell Investments Group Ltd. Increases Stake in AtriCure, Inc. (NASDAQ:ATRC)Russell Investments Group Ltd. boosted its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 8.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 156,649 shares of the medical device company's stock after buying an aApril 16, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)JPMorgan Chase & Co. boosted its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 43.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 365,183 shares of the medical device company's stock after acquiringApril 15, 2025 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Stake Decreased by Grandeur Peak Global Advisors LLCGrandeur Peak Global Advisors LLC decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 26.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 242,791 shares of the medical device compApril 14, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Buys New Position in AtriCure, Inc. (NASDAQ:ATRC)Arrowstreet Capital Limited Partnership purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 26,693 shares of the medical device company's sApril 14, 2025 | marketbeat.comAmerican Century Companies Inc. Makes New $516,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)American Century Companies Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 16,872 shares of the medical device company's stoApril 14, 2025 | marketbeat.comNorges Bank Invests $3.42 Million in AtriCure, Inc. (NASDAQ:ATRC)Norges Bank acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 111,947 shares of the medical device company's stock, valued atApril 13, 2025 | marketbeat.comAtriCure launches smaller device for heart surgeryApril 12, 2025 | uk.investing.comKennedy Capital Management LLC Acquires 172,648 Shares of AtriCure, Inc. (NASDAQ:ATRC)Kennedy Capital Management LLC lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 29.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 752,580 shares of the medical device company's stock after acquiring an additional 172,648 shaApril 12, 2025 | marketbeat.com Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.740.73▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼335▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News Today ITGR News Today ATEC News Today IART News Today OFIX News Today SRDX News Today ANGO News Today ARAY News Today RMTI News Today RSLS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
